
Sustainable Procurement: ESG Trends in the Medical Market 2026
5 min reading time

5 min reading time
ESG stands for Environmental, Social, Governance — and in 2026 it's no longer a PR exercise but a mandatory framework. For healthcare buyers, this means new reporting duties, new supplier criteria, and new responsibility.
ESG stands for Environmental, Social, Governance — and in 2026 it's no longer a PR exercise but a mandatory framework. For healthcare buyers, this means new reporting duties, new supplier criteria, and new responsibility. Here's the state of play in 2026.
For a long time, ESG was seen as a topic for industry and finance — not hospitals. That's changed fundamentally. Three drivers are behind it:
Translation for buyers: if you're still procuring in 2026 without ESG criteria, you'll fail at the next audit cycle — and in the worst case, at the next funding round.
The healthcare sector accounts for roughly 5% of national CO₂ emissions in Germany. A significant share originates in the supply chain (Scope 3). For buyers, this translates concretely to:
If you import gloves from Malaysia, you should know the conditions they were made under. The German LkSG requires active checking:
Usually unproblematic with DACH suppliers — mandatory checks for imports from Asia or Eastern Europe.
OR textiles, treatment textiles, care utensils — wherever medically justifiable, reusable concepts are replacing single-use products. Reprocessing centers are becoming part of the supply chain. Buyers need TCO models that factor in cleaning and reprocessing.
Plastic alternatives from plant-based materials (Bio-PE, PLA) in packaging and single-use items. Caution: "bio" doesn't automatically mean "biodegradable in hospital waste streams" — sorting and disposal logistics must be considered.
Large manufacturers (B. Braun, Paul Hartmann, BD) already publish Scope 1+2+3 emissions per product category. In supplier selection, this becomes measurable — those without data have a competitive disadvantage.
Manufacturers take back their equipment at end-of-life and feed materials back into the loop. First programs for infusion pumps, ventilators, and diagnostic equipment. Question for the buyer: does the supplier offer take-back?
From an ESG perspective, DACH and EU productions have a clear advantage: shorter transport routes, EU social standards met from the start, documented due diligence. That fundamentally changes the "import-from-Asia logic" of the pre-pandemic era.
If you fall under CSRD (large hospital groups, corporations), you need to collect data for each material supplier in the following categories:
This data must be audit-ready — a hard requirement.
Integrate standard questions about ESG data into every onboarding process. What does the supplier provide on CO₂, social standards, anti-corruption?
Alongside price and quality: ESG score as a third criterion. Start with 10% weighting, then increase gradually.
Manufacturers that refuse ESG data won't be compatible with compliance duties in the medium term. Signal this early.
"Excessive packaging" is a concrete reduction lever. Multiple wrappings, thick foam padding, unnecessary films — all ESG-relevant.
Active ESG drivers get better terms with sustainable suppliers, positive external image with patients and care funds, and avoid audit stress.
Spot "greenwashing": manufacturers advertising "100% sustainable" without delivering data are suspect. Real sustainability is measurable — ask for specific KPIs.
Eco-label mistakes: some "eco" packaging can't be recycled in hospital waste streams. Clarify with the housekeeping team before switching.
Discuss trade-offs honestly: sometimes ESG conflicts with hygiene or cost. Patient safety takes priority. But many options are win-win.
On ShopMed24, we already capture ESG-relevant data from our suppliers as part of the onboarding process. Most DACH suppliers on our platform meet LkSG requirements from the start. For CSRD-required buyers, we're working on structured ESG reports per supplier.
ESG in 2026 is no longer a choice — it's a procurement standard. Buyers who restructure now will have the 2027/2028 reporting duties under control. Those who wait run into audit risks and reputation problems.
The good news: many ESG measures simultaneously reduce costs (packaging material, transport routes, waste). It's a win-win discipline if you approach it structurally.
→ Sustainable procurement with DACH suppliers